Cheryl H. Baker
Cancer Research Institute of M.D. Anderson Cancer Center Orlando
FL 32806
USA
Name/email consistency: high
- Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice. Baker, C.H., Trevino, J.G., Summy, J.M., Zhang, F., Caron, A., Nesbit, M., Gallick, G.E., Fidler, I.J. Int. J. Oncol. (2006)
- Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells in human renal cell carcinoma is a primary target for therapy by tyrosine kinase inhibitors. Baker, C.H., Pino, M.S., Fidler, I.J. Neoplasia (2006)